“OncoRACT” – The First Therapy Specific RACT for Clinical Trials

Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks, like the TransCelerate Risk Assessment and Categorization Tools (RACTs), are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.

The OncoRACT library has emerged in response to the large number of challenges that today’s Oncology trials face. Specific subject safety risks, adjudication risks, therapy cycle risks, Oncology-specific outcomes and subject recruitment risks are explicitly addressed by OncoRACT.

Read more at ACT, publication: “Oncology therapy focused RACT emerges” by Moe Alsumidaie

By |2018-05-03T13:07:48+01:00May 1, 2018|Blog, News|Comments Off on “OncoRACT” – The First Therapy Specific RACT for Clinical Trials
Linda has over 20 years of experience uncovering pain points and strategizing with MedTech organisations in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all project activities meet our clients’ quality expectations.

Upcoming Events

  1. SCDM 2018 ANNUAL CONFERENCE – Seattle

    September 23 - September 26

Register Today!

Get Free Test Access